880769-95-9

Basic information

• Product Name: 1-(Benzenesulfonyl)-3-bromo-1H-pyrrolo[2,3-b]pyridine
• Synonyms: 1-(Benzenesulfonyl)-3-bromo-1H-pyrrolo[2,3-b]pyridine;1H-Pyrrolo[2,3-b]pyridine, 3-bromo-1-(phenylsulfonyl)-;3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine;1-Phenylsulfonyl-3-broMo-1H-pyrrolo[2,3-b]pyridine, 95%;3-BroMo-1-phenylsulfonyl-7-azaindole, 95%;1-(Benzenesulfonyl)-3-bromo-pyrrolo[2,3-b]pyridine;3-Bromo-1-(phenylsulfonyl)
• CAS NO: 880769-95-9
• Molecular Formula: C₁₃H₉BrN₂O₂S
• Molecular Weight: 337.2
• Product Categories: Heterocycle-Pyridine series
• Mol File: 880769-95-9.mol
• Article Data: 10

Chemical Properties

• Melting Point: 140-145 °C
• Boiling Point: 511.4 °C at 760 mmHg
• Flash Point: 263.1 °C
• Appearance: /
• Density: 1.64 g/cm³
• Storage Temp.: 2-8°C
• PKA: 0.12±0.30(Predicted)
• CAS DataBase Reference: 1-(Benzenesulfonyl)-3-bromo-1H-pyrrolo[2,3-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(Benzenesulfonyl)-3-bromo-1H-pyrrolo[2,3-b]pyridine(880769-95-9)
• EPA Substance Registry System: 1-(Benzenesulfonyl)-3-bromo-1H-pyrrolo[2,3-b]pyridine(880769-95-9)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36/37/38
• Safety Statements: 26
• WGK Germany: 3
• Hazardous Substances Data: 880769-95-9(Hazardous Substances Data)

Usage

General Description

1-(Benzenesulfonyl)-3-bromo-1H-pyrrolo[2,3-b]pyridine is a chemical compound with the molecular formula C15H10BrN3O2S. It is a pyrrolopyridine derivative that contains a sulfonyl group and a bromine atom. 1-(Benzenesulfonyl)-3-bromo-1H-pyrrolo[2,3-b]pyridine has potential applications in the field of medicinal chemistry, particularly in the development of pharmaceuticals. It may be used as a building block in the synthesis of various biologically active molecules. Additionally, its unique structural features make it a valuable tool for studying chemical reactions and mechanisms in organic synthesis. Overall, 1-(Benzenesulfonyl)-3-bromo-1H-pyrrolo[2,3-b]pyridine is a versatile compound with diverse potential uses in both research and applied settings.

Upstream product

• 98-09-9 benzenesulfonyl chloride 
• 271-63-6 7-Azaindole 
• 74420-15-8 3-bromo-1H-pyrrolo[2,3-b]pyridine 
• 143141-23-5 1-benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine 

Downstream Products

• 1001414-28-3 1-(3,4-difluorobenzyl)-N-(3-hydroxy-5-(1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)benzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1001414-27-2 1-(3,4-difluorobenzyl)-N-(3-isopropoxy-5-(1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)benzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1001413-72-4 C₁₈H₁₁N₅O₂S 
• 1001412-13-0 1-(3,4-difluorobenzyl)-N-(3-isopropoxy-5-(1H-pyrrolo[2,3-b]pyridin-3-yl)benzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide trifluoroacetic acid salt 

Relevant articles and documents

COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES

The invention relates to compounds of formula (II) for using in imaging and particularly for the diagnosis of neurodegenerative diseases

Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors

From four molecules, inspired by the structural features of fascaplysin, with an interesting potential to inhibit cyclin-dependent kinases (CDKs), we designed a new series of tri-heterocyclic derivatives based on 1H-pyrrolo[2,3-b]pyridine (7-azaindole) an

PYRROLOPYRAZINONE INHIBITORS OF KINASES

The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1a, R1b, R1c, X, Y, Z, n, and m are defined in the description. The present invention relates also to compositions cont